202-780-5153 info@nidellaw.com

Procrit, Aranesp, Epogen

Aranesp, Epogen & Procrit Death, Heart Attack, Stroke, and Blood Clots
According to the FDA, the anemia drugs, Procrit, Epogen, and Aranesp are associated with increased rates of death, heart attack, stroke, and blood clots. The FDA specifically highlighted the risk of death and other side-effects, such as heart attack, stroke, heart failure, and blood clots, for patients with chronic kidney failure. The FDA’s advisory panel also recommended against Procrit use by patients with breast cancer or head and neck cancer due to the risk of adverse events.

If a loved one died, or if you or a loved one suffered a heart attack, stroke, or blood clot while If you or a loved one have suffered from heart attack, stroke, or blood clot, or a loved one has died, from the prolonged use of Procrit, Epogen or Aranesp, you may be entitled to file a claim against the manufacturer. The time to file such a claim is limited. Do not wait to contact us, or another attorney of your choice, to investigate your potential claim.